May 31, 2017 / 11:08 AM / 2 years ago

BRIEF-Compugen ‍anticipates delay of several months in submission of investigational new drug application for COM701​

May 31 (Reuters) - Compugen Ltd:

* Compugen provides update on com701 and upcoming presentations

* Compugen Ltd - ‍anticipates a delay of several months in submission of an investigational new drug application (ind) for com701​

* Compugen Ltd - ‍previously company had disclosed an expectation of IND filing for com701 in q4 of this year​

* Compugen - informed by manufacturing service provider for com701 that batch of material manufactured for co’s glp toxicity studies was contaminated

* Compugen Ltd - “expect this delay may have a limited effect with respect to our on-going business development discussions for this program”

* Compugen - ‍contamination discovered during quality control procedures prior to release of affected batch and, as such, was not used in preclinical studies​

* Compugen Ltd - ‍contamination of com701 batch has necessitated production of a new batch of material for execution of studies​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below